TC Biopharm HoldingsTCBWFPreferred / convertible
13F holders, Q2 2024 (June 30)8holders +2
2new positions
0sold out
1famous investor
$0.01avg. 13F price*
At the end of Q2 2024, 8 institutions reported holding TC Biopharm Holdings Ltd. (TCBWF) in their 13F filings, up 2 from Q1 2024. 2 opened new positions and 0 sold out. The largest holders were Kepos Capital LP ($6K), Nantahala Capital Management, LLC ($3K) and Susquehanna International Group, LLP ($504). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- TC Biopharm Holdings Ltd.
- CUSIP
- 87807D111
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $761 |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 67,711 shares bought and 1,260 shares sold, net +66,451 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| Kepos Capital LP | — | No change | 470,588 | $6K |
| Nantahala Capital Management, LLC | — | No change | 235,294 | $3K |
| Susquehanna International Group, LLP | — | New | 37,609 | $504 |
| Citadel Advisors | — | New | 19,178 | $257 |
| Altium Capital Management LLC | — | No change | 18,823 | $235 |
| Bank of America Corp. | — | Reduce -34.4% | 382 | $5 |
| Virtu Financial LLC | — | Add +79.5% | 24,663 | $0 |
| UBS Group AG | — | Reduce -96.9% | 34 | $0 |
"% of holder's portfolio" is TCBWF's weight in each manager's 13F, not the share of TC Biopharm Holdings Ltd. the manager owns.